首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy
【24h】

In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy

机译:新型基于卟啉的光敏剂在光动力疗法中的体外和体内抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

Photodynamic therapy (PDT) is a promising treatment in cancer therapy, based on the use of a photosensitizer activated by visible light in the presence of oxygen. Nowadays significant research efforts have been focused on finding a new photosensitizer. In the present paper, the antitumor effects of a novel porphyrin-based photosensitizer, {Carboxymethyl-[2-(carboxymethyl-{[4-(10,15,20-triphenylporphyrin-5-yl)-phenylcarbamoyl]-methyl}-amino)-ethyl]-amino}-acetic acid (ATPP-EDTA) on two types of human malignant tumor cells in vitro and a gastric cancer model in nude mice, were evaluated.
机译:基于在氧气存在下被可见光激活的光敏剂的使用,光动力疗法(PDT)在癌症疗法中是一种很有前途的疗法。如今,大量的研究工作集中在寻找新的光敏剂上。在本文中,一种新型的基于卟啉的光敏剂{羧甲基-[2-(羧甲基-{[4-(10,15,20-三苯基卟啉-5-基)-苯基氨基甲酰基]-甲基}-氨基}的抗肿瘤作用评估了两种体外人恶性肿瘤细胞上的)-乙基]-氨基}-乙酸(ATPP-EDTA)和裸鼠的胃癌模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号